HM2018-13 :A GLOBAL RANDOMIZED MULTICENTER PHASE 3 TRIAL TO COMPARE THE EFFICACY ANDSAFETY OF JCAR017 TO STANDARD OF CARE IN ADULT SUBJECTS WITH HIGH-RISK, TRANSPLANTELIGIBLE RELAPSED OR REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS(TRANSFORM)

Bachanova, Veronika (PI)

Clinical and Translational Science Institute
Medicine - Hematology, Oncology, Transplant

Project: Research project

Project Details

Description

HM2018-13 :A GLOBAL RANDOMIZED MULTICENTER PHASE 3 TRIAL TO COMPARE THE EFFICACY AND SAFETY OF JCAR017 TO STANDARD OF CARE IN ADULT SUBJECTS WITH HIGH-RISK, TRANSPLANT ELIGIBLE RELAPSED OR REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS (TRANSFORM)

Status	Active
Effective start/end date	7/25/18 → 7/30/23

Funding

Celgene Corporation

View all

View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.